Serum Level Of Irisin And Some Biochemical Parameters In Patients With Acute Myocardial Infarction Serum Level Of Irisin And Some Biochemical Parameters In Patients With Acute Myocardial Infarction
Article Sidebar
Main Article Content
Abstract
Abstract
Acute myocardial infarction (AMI) is the most common form of cardiovascular disease (CVD), that leads to death. Myocardial infarction might directly increase irisin secretion through damaged cardiomyocytes. This study investigated the role of serum irisin level in myocardial infarction patients compared to control and explored its correlation with myocardial infarction in human patients. Sixty patients with acute myocardial infarction and 60 healthy control subjects were comprised in this study. Irisin level was measured using the ELISA method. The mean age of AMI patients was 61.30, 62.38, and 59.21 years for STEMI, NSTEMI, and control, respectively. The ratio of males and females with AMI was 2:1.6, where 37 (61.6%) and 23 (39.4%) were male and female, respectively. The mean irisin levels were 69.83, 72.63and 204.8 ng/ml for STEMI, NSTEMI, and control groups, respectively. In conclusion, this study approved a significant decrease in the level of the irisin AMI patients group in comparison to the healthy control group.
Keywords: Serum irisin, Biomarker, Acute Myocardial Infarction.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The Journal of Medical and Oral Biosciences uses a Creative Commons Attribution (CC Attribution-ShareAlike 4.0) and its license of (CC BY-SA 4.0). This license allows the authors to hold ownership of the copyright of their articles.
Attribution-Share Alike 4.0 International License (CC BY-SA 4.0). 
Under the CC BY-SA 4.0 the authors are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
No use, distribution or reproduction is permitted which does not comply with these terms.
https://creativecommons.org/licenses/by-sa/4.0/